TS-172
Asset
Non-absorbed phosphate binder that decreases phosphate absorption
- Stage
- Phase 3
- Modality
- Small molecule
- Target
- Not known
- 1
- Indication
- 1
- Trial
- 1
- Developer
Indications
1Hyperphosphatemia patients on hemodialysis
Phase 3, Active not recruiting, NCT07548840, clinicaltrials.gov, 7 Oct 2026
In the full profile
- Owner and partners1
- Trials1
- Signals1
Every asset’s record: target, stage, trials and the evidence behind it.